This is for informational purposes only. For medical advice or diagnosis, consult a professional. AI responses may include mistakes. Learn more
: In recent multicenter registry data (January 2017 – June 2021), a group of 459 adult patients receiving mismatched unrelated donor (MMUD) transplants with calcineurin inhibitor (CNI)-based prophylaxis was studied. GVH-459
: Typically develops within the first 100 days; affects the skin (rashes), liver (jaundice), and GI tract (diarrhea). This is for informational purposes only